PERRIGO Co plc
corporate_fare Company Profile
PERRIGO Co plc (NYSE:PRGO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for PRGO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-05, rated 8/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for PRGO spans 10-Q, 8-K, 8-K/A, DEF 14A.
Recent high-impact activity:
- Perrigo Q2 2026: $1.02B in Sales, $74.5M Net Income, and a Reaffirmed Full-Year Outlook Amid Turnaround
- Perrigo Q2 Earnings: $0.63 Reported EPS, Reaffirms 2026 Outlook Amid Turnaround
- Perrigo Finalizes Interim CEO Compensation with $2.5M RSU Grant
- Perrigo Appoints Two Experienced Independent Directors to Board, Expanding Size to 10
- Perrigo CEO Resigns Immediately Due to Personal Conduct; Interim CEO Appointed
Financial Snapshot
Short Interest & Short Volume
9.34 days to coverFINRA reported short interest of 22,639,002 shares in PRGO as of the September 15, 2026 settlement, a 0.4% increase from the prior period — about 9.3 days to cover at its recent average daily volume. On October 2, 2026, 63.5% of PRGO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.